CDRxAbs:

Jingzhou Wang1,2,3, Aiden J Aceves1,4, Nicholas J Friesenhahn2

  • 1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, United States.

概括

我们开发了CDR扩展抗体 (CDRxAbs),这是一种新型分子药物. 这些生物结合物增强了小分子结合亲和力和对标的特异性.